Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities
Net income (loss)	$ 13,604,603	$ (2,820,503)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	31,563	346,858
Gain on sale of CAKE Business	(19,473,080)
Amortization of deferred financing cost	2,511,960	384,407
Provision for bad debt	54,264	(335,801)
Fair value of options and warrants	197,773	203,486
Issuance of common stock as payment of interest	315,000
Changes in operating assets and liabilities:
Accounts receivable	(3,615)	129,609
Prepaid expenses and other current assets	172,155	(40,214)
Other assets	28,095	12,388
Accounts payable and accrued expenses	(1,928,243)	(188,443)
Deferred revenue	(284,198)
Other liabilities	(602,083)	416,393
Net cash (used in) operating activities	(5,375,806)	(1,891,820)
Cash flows from investing activities
Capitalized software for internal use		(750,000)
Purchase of property and equipment	(1,751)	(28,698)
Proceeds from sale of CAKE Business	20,892,667
Payments for acquisition of subsidiary	(420,000)
Net cash provided by (used in) investing activities	20,470,916	(778,698)
Cash flows from financing activities
Principal repayments of credit facility and loan	(11,772,514)	(2,163,212)
Proceeds from credit facility	900,000	4,702,197
Proceeds from promissory notes		1,000,000
Repayment of related party notes	(300,000)
Repayment of promissory notes	(2,700,000)
Net cash (used in) provided by financing activities	(13,872,514)	3,538,985
Effect of exchange rate fluctuations on cash	1,196	(13,517)
Net change in cash and restricted cash	1,223,792	854,950
Cash and restricted cash, beginning of the period	77,295	216,883
Cash and restricted cash, end of the period	1,301,087	1,071,833
Supplemental disclosure of cash flow information:
Interest paid	946,691	711,627
Income taxes paid
Supplemental disclosure of non-cash investing and financing information:
Fair value of warrants issued in connection with line of credit and promissory notes	44,670	2,038,296
Capital expenditure included in accounts payable		1,299
Accrued payables and short-term note directly paid off by credit facility		623,399
Prepaid expenses reclassified to deferred financing costs		70,000
Accrual of preferred stock interest	6,575
Accrued interest reclassed to credit facility	62,379
Warrant repricing adjustment	104,638
Conversion of notes payable to Series A Preferred Stock	500,000
Common Stock [Member]
Supplemental disclosure of non-cash investing and financing information:
Issuance of Series B Preferred Stock for acquisition of subsidiary	2,700,000
Series B Preferred Stock [Member]
Supplemental disclosure of non-cash investing and financing information:
Issuance of Series B Preferred Stock for acquisition of subsidiary	$ 687,000